Change over period: —
NSE · RPGLIFE
RPG LIFESCI
-19.0% from the 52-week high · +43.5% above the low
RPG Life Sciences Ltd. is engaged in the development, manufacture, and market of pharmaceutical products. The company is headquartered in Mumbai, Maharashtra. The company went IPO on 2008-06-10. The firm operates in the domestic and international markets in the formulations, generics, and synthetic active pharmaceutical ingredients (APIs) space. Its business portfolio includes domestic formulations, international formulations and APIs. Its domestic formulation business manufactures and markets branded finished dosage formulations in India. The domestic formulations business has presence in over 10 therapeutic areas, including nephrology, oncology, rheumatology, cardiology, respiratory, nutritional, gastroenterology, and diabetology, among others. The international formulations business is involved in developing, manufacturing and marketing oral solid formulations in the generic and branded generic space across regulated and emerging markets. Its products include Azoran, Mofetyl, Arpimune ME, Azathioprine, Sodium Valproate PR, Nicorandil, Quinfamide, Nicorandil, Haloperidol, Risperidone, and others.
The short version. Return on equity was 19.0% in Mar 2026. Promoter holding was 72.95% in Sep 2026, up 0.00 points over 8 quarters.
1 · The price
How has the stock traded?
RPG LIFESCI trades 19.0% below its 52-week high and 43.5% above its 52-week low.
2 · The business
Is it growing?
Reported results · ₹ crore
Revenue and profit
Show the numbers
Quarterly
| Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | |
|---|---|---|---|---|
| Revenue | 212 | 196 | 177 | 180 |
| Net profit | 27 | 31 | 30 | 22 |
| Net margin % | 12.6 | 15.7 | 16.9 | 12.3 |
| EPS (₹) | 16.08 | 18.6 | 18.08 | 13.38 |
Annual
| FY2026 | |
|---|---|
| Revenue | 708 |
| Net profit | 115 |
| Net margin % | 16.3 |
| EPS (₹) | 69.64 |
3 · The quality
How well does it turn capital into profit?
Return on equity was 19.0% in Mar 2026; debt to equity is 0.03.
Profitability · 4 years
Returns and margins
| Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | |
|---|---|---|---|---|
| Return on equity % | 19.0 | — | — | — |
| Return on capital % | 24.5 | — | — | — |
| EBITDA margin % | 24.1 | — | — | — |
| Net margin % | 15.7 | — | — | — |
Compound growth
Revenue vs profit
| 3 years | 5 years | |
|---|---|---|
| Revenue CAGR | — | — |
| Profit CAGR | — | — |
4 · The owners
Who holds it, and are they adding?
Unchanged over 8 quarters.
Down 0.43 pts over 8 quarters.
Up 3.87 pts over 8 quarters.
+1 versus the previous month.
Shareholding pattern (%)
Quarter by quarter
| Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 | Change | |
|---|---|---|---|---|---|---|---|---|---|
| Promoter | 72.95 | 72.95 | 72.95 | 72.95 | 72.95 | 72.95 | 72.95 | 72.95 | 0.0 |
| FII | 1.3 | 1.45 | 1.35 | 1.11 | 1.0 | 0.87 | 0.95 | 0.87 | -0.43 |
| DII | 6.06 | 6.14 | 6.48 | 6.7 | 7.04 | 7.45 | 8.67 | 9.93 | +3.87 |
| Public | 19.69 | 19.46 | 19.22 | 19.24 | 19.01 | 18.73 | 17.42 | 16.25 | -3.44 |
Mutual fund holdings · Oct 2026
5 schemes hold this stock
4 the month before.
- Motilal Oswal BSE Healthcare ETF0.07% of NAV
- Bandhan BSE Healthcare Index Fund0.07% of NAV
- Motilal Oswal BSE 1000 Index Fund0.01% of NAV
- ADITYA BIRLA SUN LIFE BSE TOTAL MARKET ETF0.01% of NAV
- ADITYA BIRLA SUN LIFE BSE TOTAL MARKET INDEX FUND0.01% of NAV
5 · The model view
What does our factor model say?
Factor scores, model flags and screen results for RPG LIFESCI are part of the Wright portfolio review.
Run your free portfolio reviewWatchouts
What to review
Model flags are shown inside the portfolio review, alongside your other holdings.
Related stocks
Other Pharmaceuticals & Biotechnology stocks
Quick answers
Common questions about RPG LIFESCI
What is the RPG LIFESCI share price?
RPG LIFESCI (RPGLIFE) last closed at ₹2,604.30, up 4.07% on the day. Its 52-week range is ₹1,744.00 to ₹3,089.20.
What is the market cap of RPG LIFESCI ?
RPG LIFESCI has a market capitalisation of about ₹4,142 crore. Its price-to-earnings ratio is 37.4.
How are RPG LIFESCI 's latest results?
Return on equity was 19.0% in Mar 2026. Promoter holding was 72.95% in Sep 2026, up 0.00 points over 8 quarters.
Who owns RPG LIFESCI ?
As of Sep 2026, shareholding was: Promoter 72.95%, FII 0.87%, DII 9.93%, Public 16.25%.
How many mutual funds hold RPG LIFESCI ?
5 mutual fund schemes held RPG LIFESCI in October 2026. That compares with 4 the month before.
Corporate actions
Recent dividends, bonuses and splits
- 09 Jul 2026 · Final Dividend - Rs. 24
- 27 Jun 2025 · Final Dividend - Rs. 20
- 27 Jun 2025 · Special Dividend - Rs. 4
- 28 Jun 2024 · Final Dividend - Rs. 16
- 21 Jul 2023 · Final Dividend - Rs. 12
- 14 Jul 2022 · Final Dividend - Rs. 9.6
Financials are as reported by the company (consolidated), in ₹ crore. Source: FinEdge exchange filings feed. Figures can differ from other sites because of one-off items and restatements. Callouts above are arithmetic on reported data, not recommendations.
Research data on this page is provided under Wright Research's SEBI Research Analyst registration. The Terms & Conditions of our Research Analyst services apply.